Researchers developed metabolomic aging clocks using machine learning, uncovering links between metabolite profiles, health outcomes, and lifespan.
Acrivon draws in $130M; Vincerx Pharma’s Ph1 metastatic tumor data
Acrivon raises $130M PIPE: The precision oncology biotech brought in the money from RA Capital, Perceptive Advisors and other investors. Its stock $ACRV was up